ViiV Fall Webinars

 

Please join this topic specific research discovery session covering ViiV sponsored clinical data presented at the fall webinars in 2020

GEMINI 144 Week: Efficacy and Safety - Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

Please join with ViiV Senior Medical Experts in the presentation of the GEMINI 144 week data evaluating the long term efficacy and safety comparing DTG/3TC to a 3 drug regimen
Glasgow 2020, October 2020

TANGO 96 Week: Efficacy and Safety – Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

Please join with ViiV senior Medical Experts in the presentation of the TANGO 96 week data comparing DTG/3TC to a TAF-based regimen in maintaining virologic suppression in a switch population
HIV Glasgow 2020, October 2020

GEMINI 48 Week: Adherence Analysis - Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

Please join with ViiV Senior Medical Experts in the presentation of the impact of treatment adherence on the efficacy of DTG/3TC vs DTG+TDF/FTC from the GEMINI 1 and 2 studies
Glasgow 2020, October 2020

STAT 24 Week: Feasibility, Efficacy and Safety - Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

Please join with ViiV Senior Medical Experts in evaluating the feasibility, efficacy, and safety using DTG/3TC as a first line regimen in a test and treat setting for newly diagnosed people living with HIV (PLWH)
ACTHIV 2020, August 20, 2020

Are you a US healthcare provider?

This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.

Yes

No

Connect With Our Medical Experts

Find My ViiV MSL

Easily find the ViiV Medical Science Liaison (MSL) in your area.

Request a Scientific Discussion

Submit a request for additional information from a ViiV Medical Expert.

Contact Us

Chat Live

Get immediate assistance from a ViiV Healthcare Professional.

Call 1‑888‑226‑8434

Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Our Response to COVID-19

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch